| ![]() | SMTL ID2vwm.1Ligands(4R)-4-{[(5-chlorothiophen-2-yl)carbonyl]amino}-N-(cyclopropylmethyl)-1-(2-{[2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl]amino}-2-oxoethyl)-L-prolinamide; SODIUM IONPolypeptidesACTIVATED FACTOR XA HEAVY CHAIN; FACTOR X LIGHT CHAINOligo-statehetero-1-1-mer
 | 
| ![]() | SMTL ID2vwm.2Ligands(4R)-4-{[(5-chlorothiophen-2-yl)carbonyl]amino}-N-(cyclopropylmethyl)-1-(2-{[2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl]amino}-2-oxoethyl)-L-prolinamide; SODIUM IONPolypeptidesACTIVATED FACTOR XA HEAVY CHAIN; FACTOR X LIGHT CHAINOligo-statehetero-1-1-mer
 | 
| ![]() | SMTL ID2vwm.3Ligands(4R)-4-{[(5-chlorothiophen-2-yl)carbonyl]amino}-N-(cyclopropylmethyl)-1-(2-{[2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl]amino}-2-oxoethyl)-L-prolinamide; SODIUM IONPolypeptidesACTIVATED FACTOR XA HEAVY CHAINOligo-statemonomer
 | 
| ![]() | SMTL ID2vwm.4Ligands-PolypeptidesFACTOR X LIGHT CHAINOligo-statemonomer
 | 
| ![]() | SMTL ID2vwm.5Ligands(4R)-4-{[(5-chlorothiophen-2-yl)carbonyl]amino}-N-(cyclopropylmethyl)-1-(2-{[2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl]amino}-2-oxoethyl)-L-prolinamide; SODIUM IONPolypeptidesACTIVATED FACTOR XA HEAVY CHAINOligo-statemonomer
 | 
| ![]() | SMTL ID2vwm.6Ligands-PolypeptidesFACTOR X LIGHT CHAINOligo-statemonomer
 |